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Background: The Framingham Risk Score (FRS) is a valuable tool for primary coronary heart disease (CHD) risk prediction. Modifications to the 
original 1998 model were made in 2001 and 2008. We evaluated the ability of these models to predict death, myocardial infarction (MI), and heart 
failure (HF) among those diagnosed with angiographic CHD.
Methods: We assessed the long-term risk of death, MI, and heart failure (HF) in coronary angiography pts using the original 1998 FRS, 2001 ATP 
III FRS, and 2008 FRS versions. Pts (N=6,074; 74% male) were included if they had full FRS data and no history of CHD prior to angiography. FRS 
scores were stratified into optimal[O] (<5%), low[L] (5-9%), moderate[M] (10-20%), and high[H] (>20%) CHD risk. Some moderate and high groups 
were combined due to small numbers. Average follow-up was 4.8±4.2 yrs.
Results: A large proportion of CHD pts were stratified into optimal or low FRS categories, particularly for the 1998 FRS (males: O: 2438[63.4%], 
L: 1065[27.7%], N: 334[8.7%], H: 6[0.2%]; females: O: 958[89.0%], L: 98[9.1%], N: 20[1.9%], H: 1[0.1%]). None of the FRS versions effectively 
predicted death or MI for either sex (Table). Having a high FRS occasionally predicted a better outcome.
Conclusion: The FRS has shown to effectively predict future CV events among primary prevention populations. Among pts with pre-existing 
CHD, it is ineffective in predicting future death, MI, or HF. These findings justify the development of separate risk models for secondary prevention 
populations.
